Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > European Commission Decision on Carlye/Vantive Merger
View:
Post by gebremeskel on Oct 23, 2024 5:07pm

European Commission Decision on Carlye/Vantive Merger

If I'm reading this correctly the EC was notified about the prospective Carlye/Vantive merger on 10Oct24 and will make their decision to allow or disallow (provisionally) by 26Nov24. 

https://competition-cases.ec.europa.eu/cases/M.11732?from=latest-updates&caseInstrument=M&dateHighlight=2024-10-23

The issue to be decided is to whether or not the merger will impede the proper functioning of the EU's internal market by reducing competition.

https://www.europarl.europa.eu/factsheets/en/sheet/82/competition-policy

Description of the concentration:

https://ec.europa.eu/competition/mergers/cases1/202443/M_11732_10306117_204_3.pdf
Comment by gebremeskel on Oct 23, 2024 5:10pm
Actually, the EC was notified on 21Oct24 not 10Oct24
Comment by BlueJays9293 on Oct 23, 2024 7:09pm
I had completely forgoten that they also needed EU approval and not just FTC approval.  Thank you for pointing this out, and bringing the receipts to boot!  I am of the opinion that this is a regulatory rubber stamp moment for the CG/Vantive deal, as I see zero potential for this deal to reduce market competition.  This deal isn't like when Fresenius took over NxStage, and ...more  
Comment by mercedesman on Oct 23, 2024 10:02pm
I agree. i can't imagine the Europeans being bothered by a change in ownership from a Division of much larger entity, to an independently owned one... both headquartered in the far off land of America ( even if all three entities do business in Europe )  It's really more of a de-monopolization  More of a necessary formality IMO  MM PS I wonder if Spectral will ...more  
Spectral Medical Inc